Medacta Group SA (CH:MOVE)
:MOVE
Switzerland Market
Advertisement

Medacta Group SA (MOVE) Technical Analysis

Compare
3 Followers

Summary of all the Indicators

Overall Consensus
Strong Buy
16Bullish
4Neutral
2Bearish
Technical Analysis Consensus
Buy
4Bullish
4Neutral
2Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
Medacta Group SA’s (MOVE) Moving Averages Convergence Divergence (MACD) indicator is 0.61, suggesting Medacta Group SA is a Sell.
Medacta Group SA’s (MOVE) 20-Day exponential moving average is 148.33, while Medacta Group SA’s (MOVE) share price is CHF152, making it a Buy.
Medacta Group SA’s (MOVE) 50-Day exponential moving average is 147.64, while Medacta Group SA’s (MOVE) share price is CHF152, making it a Buy.

Medacta Group SA (MOVE) Pivot Points

Nov 18, 2025, 04:28 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
144.67
148.13
150.87
154.33
157.07
160.53
163.27
Fibonacci
148.13
150.50
151.96
154.33
156.70
158.16
160.53
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Medacta Group SA (MOVE) Moving Averages

Nov 18, 2025, 04:28 AM
Period
Simple
Exponential
MA5
150.68Buy
150.65Buy
MA10
147.66Buy
149.10Buy
MA20
148.16Buy
148.33Buy
MA50
148.57Buy
147.64Buy
MA100
145.96Buy
144.79Buy
MA200
138.51Buy
136.51Buy
Medacta Group SA’s (MOVE) 10-Day exponential moving average is 149.10, while Medacta Group SA’s (MOVE) share price is CHF152, making it a Buy.
Medacta Group SA’s (MOVE) 100-Day exponential moving average is 144.79, while Medacta Group SA’s (MOVE) share price is CHF152, making it a Buy.
Medacta Group SA’s (MOVE) stock price is CHF152 and Medacta Group SA’s (MOVE) 50-day simple moving average is 148.57, creating a Buy signal.
Medacta Group SA’s (MOVE) stock price is CHF152 and Medacta Group SA’s (MOVE) 100-day simple moving average is 145.96, creating a Buy signal.
Medacta Group SA’s (MOVE) stock price is CHF152 and Medacta Group SA’s (MOVE) 200-day simple moving average is 138.51, creating a Buy signal.

Medacta Group SA (MOVE) Technical Indicators

Nov 18, 2025, 04:28 AM
Name
Value
Implied Action
RSI (14)
57.71
Neutral
STOCH (9,6)
79.03
Neutral
STOCHRSI (14)
79.03
Neutral
MACD (12,26)
0.61
Sell
ADX (14)
15.60
Buy
Williams %R
-31.52
Buy
CCI (14)
116.18
Sell
ATR (14)
3.54
-
Ultimate Oscillator
53.38
Neutral
ROC
2.43
Buy
Medacta Group SA’s (MOVE) Relative Strength Index (RSI) is 57.71, creating a Neutral signal.
Medacta Group SA’s (MOVE) Trend Strength Indicator (ADX) is 15.60, creating a Buy signal.
Medacta Group SA’s (MOVE) Commodity Channel Index (CCI) is 116.18, creating a Sell signal.
Medacta Group SA’s (MOVE) Price Rate of Change (ROC) is 2.43, creating a Buy signal.

FAQ

Is MOVE a Buy, Hold, or Sell?
Based on MOVE’s technical indicators, MOVE is a Strong Buy.
    What is MOVE’s RSI (14)?
    MOVE’s RSI (14) is 57.71, which suggests MOVE is a Neutral.
      What is MOVE’s MACD?
      MOVE’s MACD is 0.61, which suggests MOVE is a Sell.
        What is MOVE’s 5-day moving average?
        MOVE’s 5-day moving average is 150.68, which suggests MOVE is a Buy.
          What is MOVE’s 20-day moving average?
          MOVE 20-day moving average is 148.16, which suggests MOVE is a Buy.
            What is MOVE’s 50-day moving average?
            MOVE’s 50-day moving average is 148.57, which suggests MOVE is a Buy.
              What is MOVE’s 200-day moving average?
              MOVE’s 200-day moving average is 138.51, which suggests MOVE is a Buy.
                What is MOVE’s Williams % R (14)?
                MOVE’s Williams % R (14) is -31.52, which suggests MOVE is a Buy.
                  What is MOVE’s CCI (14)?
                  MOVE’s CCI (14) is 116.18, which suggests MOVE is a Sell.
                    What is the share price of Medacta Group SA?
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis